(Q39489252)

English

The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway (English)

1 reference

Europe PubMed Central

12 September 2017

apoptotic process

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Gangadhara Reddy Sareddy

1

1 reference

Europe PubMed Central

12 September 2017

Khamushavalli Geeviman

2

1 reference

Europe PubMed Central

12 September 2017

Chinta Ramulu

3

1 reference

Europe PubMed Central

12 September 2017

Phanithi Prakash Babu

4

1 reference

Europe PubMed Central

12 September 2017

publication date

17 August 2011

1 reference

Europe PubMed Central

12 September 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

12 September 2017

106

1 reference

Europe PubMed Central

12 September 2017

1

1 reference

Europe PubMed Central

12 September 2017

99-109

1 reference

Europe PubMed Central

12 September 2017

https://scigraph.springernature.com/pub.10.1007/s11060-011-0662-x

0 references

Identification of human brain tumour initiating cells

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Accumulation of genetic defects during astrocytoma progression

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Genetic alterations and signaling pathways in the evolution of gliomas

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Glioma invasion in the central nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

COX-2-Specific inhibitors--the emergence of a new class of analgesic and anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Cyclooxygenase inhibitors induce apoptosis in oral cavity cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Celecoxib induces p53-PUMA pathway for apoptosis in human colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Aspirin, NSAIDS, and colon cancer prevention: mechanisms?

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Inhibition of NF-kappaB and AP-1 activation by R- and S-flurbiprofen

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Phase I/II study of selective cyclooxygenase-2 inhibitor celecoxib as a radiation sensitizer in patients with unresectable brain metastases.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Phase II trial of irinotecan plus celecoxib in adults with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

NF-kappaB in cancer: from innocent bystander to major culprit

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Missing pieces in the NF-kappaB puzzle

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Cell cycle regulation of NF-kappa b-binding activity in cells from human glioblastomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Mustard NPR1, a mammalian IkappaB homologue inhibits NF-kappaB activation in human GBM cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Inhibition of human brain tumor cell growth by the anti-inflammatory drug, flurbiprofen

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-011-0662-X

21 January 2018

Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase in biology and disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib exhibits the greatest potency amongst cyclooxygenase (COX) inhibitors for growth inhibition of COX-2-negative hematopoietic and epithelial cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination celecoxib and temozolomide in C6 rat glioma orthotopic model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microsomal prostaglandin E synthase-1 is overexpressed in head and neck squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21847707

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-011-0662-X

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39489252&oldid=1830889018"